市场调查报告书
商品编码
1541705
2024-2032 年医疗美容市场报告(按产品(设备、美容植入物)、应用(手术、非手术)、最终用户(医院和诊所、医疗水疗中心和美容中心)和地区)Medical Aesthetics Market Report by Product (Devices, Aesthetic Implants), Application (Surgical, Non Surgical), End User (Hospitals and Clinics, Medical Spas and Beauty Centers), and Region 2024-2032 |
IMARC Group年全球医学美容市场规模达168亿美元。该市场的主要驱动因素是人们对年轻外表和自信的日益重视、消费者对非侵入性整容手术的需求不断增长、技术的不断进步以及医学美容的广泛普及和可及性。
主要市场驱动因素:肉毒桿菌、真皮填充剂和雷射治疗等非侵入性或微创手术的日益普及,是推动医疗美容市场前景的关键因素之一。此外,越来越多的社群媒体平台和不断增长的名人文化也在催化全球市场。此外,医疗领域的不断进步,包括雷射技术、超音波治疗和先进的注射剂,以开发更有效、更安全的方法,正在对市场成长产生积极影响。
主要市场趋势:消费者对根据个人需求和偏好量身定制的个人化治疗计划的需求不断增长,这是一个重要的成长诱导因素。除此之外,注射剂、雷射治疗、射频治疗和护肤程序等联合疗法的新兴趋势也刺激了医疗美容市场的统计数据。
竞争格局:医疗美容行业的一些主要市场参与者包括 ARC Laser Gmbh、AbbVie Inc.、Alma Lasers Ltd.、Bausch Health Companies Inc.、Cutera Inc.、Cynosure、El.En。 SpA、Fotona doo、强生、Lutronic、Merz Pharma GmbH & Co. KGaA、Venus Concept 等。
地理趋势:由于化妆品行业的不断扩大、医疗基础设施的先进以及个人对自我完善和个人外表的日益关注,北美占据了最大的市场份额。除此之外,消费者对手术和非手术美容治疗偏好的转变也促进了该地区医疗美容市场的成长。
挑战与机会:政府机构实施严格的法规可能会为市场准入、产品审批和安全标准合规带来众多挑战。然而,人工智慧(AI)、机器人和3D列印等先进技术的日益普及,为医学美容行业的成长提供了巨大的成长机会。
对非侵入性手术的需求不断增长
对非侵入性手术的需求不断增长主要推动了市场的成长。除此之外,消费者对美容增强的偏好的转变也促进了医学美容市场的前景。此外,各种美容疗程的日益普及,如真皮填充剂、肉毒桿菌注射和雷射疗法,进一步促进了市场的成长。例如,2021 年 7 月,艾尔建 (Allergan) 获得美国 FDA 批准 BOTOX 标籤扩展,包括八种新肌肉,用于治疗成人上肢痉挛。用于治疗的新肌肉包括手肘和前臂的额外肌肉(肱肌、肱桡肌、旋前圆肌和旋前方肌)。美国整形外科医生协会的研究发现,肉毒桿菌注射是 2020 年最受欢迎的非侵入性整容手术,全年进行了 440 万例手术。因此,肉毒桿菌毒素在美容医学中的使用显着增加。肉毒桿菌注射用于治疗皱眉纹、鱼尾纹和额头横纹,这些都是美国 FDA 批准的美容适应症。
持续的技术进步
雷射技术、注射和能量设备的持续创新正在对市场成长产生积极影响。此外,由于先进技术的有效性和多功能性,针对特定皮肤问题(包括色素沉着、皱纹和纹身去除)的需求不断提高,也促进了医学美容行业的成长。例如,达文西手术系统等手术机器人的广泛使用为外科医生在微创手术过程中提供了更高的精确度、灵巧性和控制力,从而彻底改变了手术领域。此外,更持久、更自然的注射剂的日益流行也刺激了医疗美容市场的需求,这些注射剂使美容增强更容易获得併吸引个人。例如,乳房美容领域的历史悠久的品牌 GC Aesthetics 和医疗保健解决方案的先驱 Bimini Health Tech(“Bimini”)宣布建立合资伙伴关係,旨在彻底改变全球乳房重建。这项策略合作将 GC Aesthetics 在硅胶乳房植入物设计、製造和分销方面 40 年的经验与 Bimini 在乳房重建创新方面的专业知识相结合。结果是:前所未有地致力于为全球(包括美国、拉丁美洲、欧洲、中东和非洲和亚太地区)女性提供一流的乳房重建解决方案。
人们越来越重视自信和年轻的外表
根据医疗美容市场概况,优先考虑自信和年轻的文化转变是支撑医疗美容市场的主要因素之一。此外,各个监管机构对产品的批准也促进了市场的成长。例如,2022 年 1 月,Lumenis 在英国推出了 Splendor X 设备,该设备获得了 CE 许可,用于除毛、血管治疗、色素性病变和皱纹。此外,肉毒桿菌毒素治疗的日益普及、爱美人群的不断增加以及产品的推出也推动了该细分市场的成长。肉毒桿菌毒素是由肉毒桿菌产生的神经毒性蛋白质。肉毒桿菌注射往往会阻断注射肌肉的神经讯号。另据报导,31-45 岁的患者最常寻求 A 型肉毒桿菌美容手术。除此之外,ISAPS于2021年12月发布的一项调查显示,2020年全球进行的所有非手术整容手术中,43.2%是肉毒桿菌手术。
IMARC Group提供了对每个细分市场的主要趋势的分析,以及 2024-2032 年全球、区域、国家层面的预测。我们的报告根据产品、应用和最终用户对市场进行了分类。
装置
美容植入物
该报告根据产品提供了详细的市场细分和分析。这包括设备和美容植入物。根据该报告,美容植入物代表了最大的部分。美容植入物越来越受欢迎,例如隆乳和脸部增强手术,正在推动市场成长。例如,2022年5月,GC Aesthetics, Inc.推出了FixNip NRI,即乳头乳晕复合体重建植入物,以满足女性的临床需求。此外,消费者对个人化、自然效果的需求不断增长也促进了市场的成长。
外科
非手术
该报告根据应用程式提供了详细的市场细分和分析。这包括手术和非手术。报告称,手术占据了最大的市场份额。由于能够提供全面且持久的效果,医疗美容外科手术的日益普及,主要推动了市场的成长。例如,GC Aesthetics 在欧洲推出了下一代乳房植入物 PERLE,这是一个采用表面技术 (BioQ) 的高度创新的光滑乳房植入物系列。此次发布帮助该公司提供了最广泛的产品组合,包括完整的表面、填充物、尺寸和投影选择,以满足每位患者和外科医生对重建和美容手术的需求。
医院和诊所
医疗水疗美容中心
该报告提供了基于最终用户的详细市场细分和分析。这包括医院和诊所以及医疗水疗中心和美容中心。报告称,医院和诊所是最大的部分。这些老牌医疗机构凭藉其经验丰富的医护人员和全面的资源,提供各种医美服务。此外,医院和诊所是寻求手术治疗的患者的首选,因为它们为复杂的治疗提供了安全且受监管的环境。
北美洲
美国
加拿大
亚太
中国
日本
印度
韩国
澳洲
印尼
其他的
欧洲
德国
法国
英国
义大利
西班牙
俄罗斯
其他的
拉丁美洲
巴西
墨西哥
其他的
中东和非洲
该报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,由于医疗保健基础设施的不断发展以及手术和非手术整容手术的需求不断增加,北美占据了最大的市场份额。除此之外,不断增加的产品推出和领先企业的高度集中也推动了市场的成长。例如,Alma Lasers 推出了 Alma PrimeX,这是用于身体轮廓和皮肤紧緻的终极非侵入性平台。此外,医疗机构数量的增加和先进技术的利用也刺激了该地区市场的成长。例如,NanoPass Technologies 和 Aesthetic Management Partners (AMP) 签署了一项协议,将 NanoPass 的 MicronJet 600 皮内输送设备在美国商业化。
市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。医学美容行业的一些主要市场参与者包括 ARC Laser Gmbh、AbbVie Inc.、Alma Lasers Ltd.、Bausch Health Companies Inc.、Cutera Inc.、Cynosure、El.En。 SpA、Fotona doo、强生、Lutronic、Merz Pharma GmbH & Co. KGaA、Venus Concept 等。
(请注意,这只是关键参与者的部分列表,报告中提供了完整列表。)
2023 年 10 月:乳房美容领域历史悠久的品牌 GC Aesthetics 与医疗保健解决方案先驱 Bimini Health Tech(「Bimini」)宣布建立突破性的合资伙伴关係,旨在彻底改变全球乳房重建。这项策略合作将 GC Aesthetics 在硅胶乳房植入物设计、製造和分销方面 40 年的经验与 Bimini 在乳房重建创新方面的专业知识相结合。
2024 年 1 月:United Aesthetics Alliance(「UAA」或「公司」)是一家控股公司,旨在巩固市场领先的临床差异化整形外科实践和附属医疗水疗服务提供商,今天宣布它最近与 The本特森美容与整形外科中心(“BCAPS”或“诊所”)。
2024 年 2 月:新兴的纯皮肤科领域领导者 Galderma 推出了「NEXT by Galderma」。 NEXT 是一份开创性的报告,深入探讨了 2024 年及以后的全球美学趋势。该计画是与知名专家网络合作进行的一年全面趋势预测研究的结晶。
2024 年 3 月:全球最大的专业医疗美容企业之一 Merz Aesthetics 宣布对其首个多年期活动“Beauty on Your terms”进行最新扩展,并邀请了获奖演员和音乐家Demi Lovato 成为最新的XEOMIN (incobotulinumtoxinA ) 品牌合作伙伴。
The global medical aesthetics market size reached US$ 16.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.7 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032. The market is primarily driven by the rising emphasis on youthful appearance and self-confidence, the escalating consumer demand for non-invasive cosmetic procedures, the continuous technological advancements, and the widespread availability and accessibility of medical aesthetics.
Major Market Drivers: The growing popularity of non-invasive or minimally invasive procedures, such as Botox, dermal fillers, and laser treatments, is among the key factors propelling the medical aesthetics market outlook. Moreover, the increasing number of social media platforms and the growing celebrity culture are also catalyzing the global market. Additionally, the continuous advances in the medical field, including laser technology, ultrasound treatments, and advanced injectables for the development of more effective and safer methods, are positively influencing the market growth.
Key Market Trends: The escalating consumer demand for personalized treatment plans tailored to their individual needs and preferences is acting as a significant growth-inducing factor. Besides this, the emerging trend of combination therapies, such as injectables, laser cures, radiofrequency treatments, and skincare routines to achieve optimal outcomes is also stimulating the medical aesthetics market statistics.
Competitive Landscape: Some of the major market players in the medical aesthetics industry include A.R.C. Laser Gmbh, AbbVie Inc., Alma Lasers Ltd., Bausch Health Companies Inc., Cutera Inc., Cynosure, El.En. S.p.A., Fotona d.o.o., Johnson & Johnson, Lutronic, Merz Pharma GmbH & Co. KGaA, Venus Concept, among many others.
Geographical Trends: North America accounted for the largest market share, on account of the expanding cosmetic industry, the advanced medical infrastructure, and the increasing focus on self-improvement and individual appearance among individuals. Apart from this, the shifting consumer preferences towards surgical and non-surgical beauty treatments are also catalyzing the market growth of medical aesthetics in the region.
Challenges and Opportunities: The implementation of stringent regulations by government bodies can pose numerous challenges for market entry, product approval, and compliance with safety standards. However, the growing popularity of advanced technologies, including artificial intelligence (AI), robotics, and 3D printing, presents significant growth opportunities for the medical aesthetics industry growth.
Growing Demand for Non-Invasive Procedures
The escalating demand for non-invasive procedures is primarily driving the market growth. Besides this, the shifting consumer preferences towards cosmetic enhancements are also catalyzing the medical aesthetics market outlook. Moreover, the growing popularity of various beauty treatments, such as dermal fillers, Botox injections, and laser therapy is further augmenting the market growth. For instance, in July 2021, Allergan received the US FDA approval of a label expansion of BOTOX to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, pronator teres, and pronator quadratus). The American Society of Plastic Surgeons study found that Botox injections were the most popular non-invasive cosmetic procedure in 2020, with 4.4 million procedures performed in the year. Hence, the use of botulinum toxins in aesthetic medicine has increased remarkably. Botox injections are used to treat frown lines, crow's feet, and horizontal forehead lines, which are cosmetic indications approved by the US FDA.
Ongoing Technological Advancements
The ongoing innovations in laser technology, injectables, and energy-based devices are positively influencing the market growth. Moreover, the elevating requirement for advanced technologies to target specific skin issues, including pigmentation, wrinkles, and tattoo removal, owing to their effectiveness and versatility, is also catalyzing the medical aesthetics industry growth. For example, the extensive utilization of surgical robots, such as the da Vinci Surgical System, has revolutionized the field of surgery by providing enhanced precision, dexterity, and control to surgeons during minimally invasive procedures. Additionally, the growing popularity of longer-lasting and more natural-looking injectables to make cosmetic enhancements more accessible and appealing to individuals is also stimulating the medical aesthetics market demand. For instance, GC Aesthetics, a long-established brand in breast aesthetics, and Bimini Health Tech ("Bimini"), a pioneer in healthcare solutions, announced their joint venture partnership aimed at revolutionizing breast reconstruction worldwide. This strategic collaboration combines GC Aesthetics' 40 years' experience in design, manufacturing, and distribution of Silicone Breast Implants with Bimini's expertise in Breast Reconstruction innovation. The result: an unprecedented commitment to providing women with best-in-class solutions for breast reconstruction across the globe, including the USA, LATAM, EMEA, and APAC.
Rising Emphasis on Self-Confidence and Youthful Appearance
As per the medical aesthetics market overview, the rising cultural shift towards prioritizing self-assurance and youthfulness is among the primary factors bolstering the medical aesthetics market. Additionally, the approval of products by various regulatory authorities is also boosting the market's growth. For instance, in January 2022, Lumenis launched the Splendor X device, CE cleared for hair removal, vascular treatments, pigmented lesions, and wrinkles in the United Kingdom. Moreover, the growing popularity of botulinum toxin procedures, the increasing beauty-conscious populations, and the launch of products are also propelling the growth of the market segment. Botulinum toxin is a neurotoxic protein produced by the bacterium clostridium botulinum. The botulinum toxin injections tend to block the nerve signals to the muscle in which it is injected. It is also reported that patients aged 31- 45 year most commonly seek botulinum toxin type A cosmetic procedures. Apart from this, an ISAPS survey released in December 2021 revealed that among all the non-surgical cosmetic procedures performed globally in 2020, 43.2% were Botulinum Toxin procedures.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.
Devices
Aesthetic Implants
The report has provided a detailed breakup and analysis of the market based on the product. This includes devices and aesthetic implants. According to the report, aesthetic implants represented the largest segment. The growing popularity of aesthetic implants for procedures, such as breast augmentation and facial enhancements is propelling the market growth. For example, in May 2022, GC Aesthetics, Inc. launched FixNip NRI, its Nipple Areola Complex Reconstruction Implants, to cater to women's clinical needs. Moreover, the escalating consumer demand for personalized, natural-looking results is also catalyzing the market growth.
Surgical
Non Surgical
The report has provided a detailed breakup and analysis of the market based on the application. This includes surgical and non-surgical. According to the report, surgical accounted for the largest market share. The growing popularity of surgical procedures in medical aesthetics, on account of their ability to provide comprehensive and long-lasting results, is primarily driving the market growth. For instance, GC Aesthetics launched PERLE, the next generation of breast implants, a highly innovative line of smooth breast implants with surface technology (BioQ), in Europe. This launch helped the company to offer the broadest product portfolio with a full selection of surfaces, fillings, sizes, and projections to meet every patient's and surgeon's demands for both reconstructive and aesthetic procedures.
Hospitals and Clinics
Medical Spas and Beauty Centers
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics and medical spas and beauty centers. According to the report, hospitals and clinics represented the largest segment. These established healthcare facilities provide various medical aesthetic services, on account of their experienced medical staff and comprehensive resources. Moreover, hospitals and clinics are a preferred choice for patients seeking surgical procedures, as they offer a secure and regulated environment for complex treatments.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share, owing to the increasing healthcare infrastructure development and the escalating demand for surgical and non-surgical cosmetic procedures. Apart from this, the rising product launches and the high concentration of leading players are also propelling the market growth. For example, Alma Lasers launched Alma PrimeX, the ultimate non-invasive platform for body contouring and skin tightening. Moreover, the elevating number of medical institutions and the utilization of advanced technologies are also stimulating the growth of the market in the region. For instance, NanoPass Technologies and Aesthetic Management Partners (AMP) signed an agreement to commercialize NanoPass's MicronJet 600 intradermal delivery device in the United States.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Medical Aesthetics industry include A.R.C. Laser Gmbh, AbbVie Inc., Alma Lasers Ltd., Bausch Health Companies Inc., Cutera Inc., Cynosure, El.En. S.p.A., Fotona d.o.o., Johnson & Johnson, Lutronic, Merz Pharma GmbH & Co. KGaA, Venus Concept, among many others.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
October 2023: GC Aesthetics, a long-established brand in breast aesthetics, and Bimini Health Tech ("Bimini"), a pioneer in healthcare solutions, announced their groundbreaking Joint Venture partnership aimed at revolutionizing breast reconstruction worldwide. This strategic collaboration combines GC Aesthetics' 40 years' experience in design, manufacturing, and distribution of Silicone Breast Implants with Bimini's expertise in Breast Reconstruction innovation.
January 2024: United Aesthetics Alliance ("UAA" or "the Company"), a holding company created to consolidate market-leading, clinically differentiated plastic surgery practices and affiliated medical spa service providers, today announced it has recently established a new partnership with The Bengtson Center for Aesthetics & Plastic Surgery ("BCAPS" or "the Practice").
February 2024: Galderma, the emerging pure-play dermatology category leader, presented "NEXT by Galderma." A ground-breaking report, NEXT takes a deep-dive into the global aesthetics trends set to shape 2024 and beyond. This project is the culmination of a year of comprehensive trend-forecasting research, conducted in collaboration with a network of renowned experts.
March 2024: Merz Aesthetics, the one of the world's largest dedicated medical aesthetics businesses, announced the latest extension of their first-of-its kind, multi-year campaign, 'Beauty on Your Terms' with the addition of award-winning actor and musician Demi Lovato as the newest XEOMIN (incobotulinumtoxinA) brand partner.